Status:
COMPLETED
Continuous Glucose Monitoring to Measure Effect of Glycemic Index
Lead Sponsor:
Legacy Health System
Collaborating Sponsors:
Juvenile Diabetes Research Foundation
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: Post-prandial hyperglycemia is common in people with type 1 diabetes. Objective: The aim was to determine the impact of low vs high glycemic index (GI) on post-prandial glycemia for break...
Detailed Description
A total of 14 diet studies (each with two meals) were completed in three men and four women. All subjects completed two diet studies in which two meals were served 195 minutes apart. On one study day,...
Eligibility Criteria
Inclusion
- clinical diagnosis of type 1 diabetes mellitus
- patients on insulin pump therapy
Exclusion
- Any patient who was
- pregnancy
- cardiovascular, cerebrovascular, kidney, or liver disease
- uncontrolled chronic medical conditions
- oral or parenteral corticosteroid use
- immunosuppressant use
- visual or physical impairments that impede the use of a continuous glucose monitoring device
- insulin or glucagon allergy
- hypoglycemia unawareness
- requirement of greater than 200 units of insulin per day
- gastroparesis
- any prior gastric surgery
- an allergy to any food items served.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT01145547
Start Date
April 1 2009
End Date
October 1 2009
Last Update
October 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Legacy Health System--Holladay Park Campus
Portland, Oregon, United States, 97232